Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Mar. 31, 2020
Current assets:    
Cash and cash equivalents $ 4,320 $ 3,691
Accounts receivable, net 5,279 4,062
Inventories, net 3,704 2,192
Prepaid expenses and other current assets 2,770 2,256
Current portion of deferred consideration, net of discount 194 182
Total current assets 16,267 12,383
Operating lease right-of-use assets 634 963
Property and equipment, net 370 365
Deferred consideration, net of discount, less current portion 770 786
Other assets 104 64
Total assets 18,145 14,561
Current liabilities:    
Accounts payable 3,202 2,086
Accrued expenses and other current liabilities 932 1,774
Deferred revenue 150 228
Deferred revenue Invekra 48 45
Operating lease liabilities 188 251
Current portion of long-term debt 49 481
Total current liabilities 4,569 4,865
Operating lease liabilities - non-current 469 746
Long-term deferred revenue Invekra 235 245
Long-term debt 1,310 0
Total liabilities 6,583 5,856
Commitments and Contingencies (Note 6)
Stockholders' Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at September 30, 2020 and March 31, 2020, respectively, 0 and 1.55 shares issued and outstanding at September 30, 2020 and March 31, 2020, respectively 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized at September 30, 2020 and March 31, 2020, 2,041,409 and 1,777,483 shares issued and outstanding at September 30, 2020 and March 31, 2020, respectively 2 2
Additional paid-in capital 188,701 186,559
Accumulated deficit (171,886) (172,246)
Accumulated other comprehensive loss (5,255) (5,610)
Total stockholders' equity 11,562 8,705
Total liabilities and stockholders' equity $ 18,145 $ 14,561